Bruce Colwill | Chief Financial Officer |
Eric Adams | President and Chief Executive Officer |
Eric Hsu | Senior Vice President, Preclinical Research and Development |
Alexandra Mancini | Senior Vice President, Clinical and Regulatory Affairs |
Michael Woudenberg | Vice President, Chemistry, Manufacturing and Control |
Scott Henry | ROTH Capital Markets |
Good morning. My name is Sara and I will be your conference operator today. At this time, I would like to welcome everyone to InMed’s Third Quarter 2021 Financial Results and Business Update Conference Call for the fiscal quarter ended March 31, 2021. [Operator Instructions] Mr. Colwill, you may begin your conference.